NCT02343211View on ClinicalTrials.gov

Immunotherapy and Paraneoplastic Neurological Syndromes

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

December 31, 2016

Conditions
Paraneoplastic Neurological Syndromes
Interventions
DRUG

Immunoglobulin

Trial Locations (1)

75013

Groupe Hospitalier Pitié Salpetrière, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02343211 - Immunotherapy and Paraneoplastic Neurological Syndromes | Biotech Hunter | Biotech Hunter